First Command Advisory Services’s Teva Pharmaceuticals TEVA Stock Holding History

First Command Advisory Services’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.1K	Buy	1,362 +1,038	+320%	+$34.6K	﹤0.01%	462
2026 Q1	$9.76K	Buy	+324	New	+$10.4K	﹤0.01%	618
2018 Q1	–	Sell	-30	Closed	–	–	53
2017 Q4	$0	Buy	+30	New	+$451	﹤0.01%	49

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

First Command Advisory Services's TEVA Position: Q2 2026 in Review

First Command Advisory Services increased its Teva Pharmaceuticals (TEVA) stake by 320% in Q2 2026, buying an estimated $34.6K and bringing the position to 1,362 shares worth $46.1K. The position accounts for ﹤0.01% of the portfolio, ranked #462.

First Command Advisory Services first reported a position in TEVA in Q4 2017 and has held it in 3 quarters since. 674 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

First Command Advisory Services held 1,362 shares of Teva Pharmaceuticals worth $46.1K as of Q2 2026.
First Command Advisory Services bought 1,038 Teva Pharmaceuticals shares in Q2 2026, an estimated $34.6K.
Teva Pharmaceuticals made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #462 holding.
First Command Advisory Services first reported a position in Teva Pharmaceuticals in Q4 2017 and has held it in 3 quarters since.
674 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.